Newsworks: Aetna lowers cost of HIV drugs in wake of pricing controversy

Newsworks: Aetna lowers cost of HIV drugs in wake of pricing controversy

By Elana Gordon

Aetna is changing the drug benefits in all of its individual health plans effective June 1, lowering the patient costs for HIV drugs.

The National Health Law Program filed a federal complaint alleging insurers engaged in the practice called “adverse tiering” in Florida last year. The federal government has issued guidelines discouraging the practice.

“It does no good to get the insurance if, once you get the insurance, you can’t afford the prescription drugs that are provided under the plan, ” said NHeLP director Elizabeth TaylorRead the full article here. »

Related Content

#GivingTuesday

Support our work to advance health rights for low-income and underserved individuals with a donation today!

 

DONATE NOW